New research published today in Nature Communications, describes how CRISPR-Cas9 gene editing can be used to create new nonribosomal peptide synthetase (NRPS) enzymes that deliver clinically important ...
These enzymes, AARSs for short, link transfer RNAs (tRNAs ... “By the time you get to humans, the synthetase has become highly decorated” with those additional domains, says Paul Schimmel, a Scripps ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback